← Eichor
Study identifier: NCT04086082 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging

Condition: Lung Cancer  ·  Sponsor: University of Sydney

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This trial will investigate the feasibility of the Markerless Tumour Tracking technology.

This description comes directly from the study's public registry record.

Talk to the study team

Trial Coordinator  ·  +61 2 8627 1185  ·  shona.silvester@sydney.edu.au

Research Student  ·  +61 2 8627 1185  ·  Jonathan.Hindmarsh@sydney.edu.au

Always discuss trial participation with your own doctor first.

Locations (1)

Alfred HealthMelbourne, Victoria, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04086082